Cannabis for Multiple Sclerosis
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to examine the effect of Cannabis components, THC and CBD, on cognition and bladder symptoms in people with Multiple Sclerosis (MS).
Participants will complete questionnaires and cognitive tests. They will be randomly assigned to receive either CBD or THC oil and will take the study drug for 15 weeks.
Are You a Good Fit for This Trial?
This trial is for adults with Multiple Sclerosis who have bladder symptoms scored at least 7 on the NBSS. They must use contraception if applicable, agree to study terms, and have a stable medication routine for bladder issues if they're already being treated.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Cannabis (THC vs. CBD)
Trial Overview
The trial tests how THC or CBD oils affect cognition and bladder control in MS patients over 15 weeks. Participants will be randomly given either oil and complete cognitive tests and questionnaires throughout the study.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
THC oil will be administered orally once a day for 15 weeks.
CBD oil will be administered orally once a day for 15 weeks.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Multiple Sclerosis Society of Canada
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.